|
| |
BioPortfolio's Approved Drugs DatabaseFemringEstradiol AcetateDownload PDF containing detailed information.
Press Releases About Femring:
|
 |
| Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB) |
21st May, 2009 |
Watson Pharmaceuticals, Inc. |
- Bold and innovative marketing campaign will target women and highlight product's efficacy, ease of use and excellent tolerability -
CORONA, Calif., May 21 /PRNewswire-FirstCall/ -- Watson
|
| RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days |
8th May, 2009 |
Watson Pharmaceuticals, Inc. |
- Significant peak urine flow (Qmax) improvements within 2-6 hours of the first dose, according to published data -
CORONA, Calif., May 8 /PRNewswire-FirstCall/ -- RAPAFLO(TM) (silodosin), a new,
|
| Presented Data Confirm That RAPAFLO(TM) (silodosin) Provides Rapid, Highly Effective, Symptom Relief for Benign Prostatic Hyperplasia (BPH) Patients |
28th April, 2009 |
Watson Pharmaceuticals, Inc. |
- Uniquely Selective Agent Offers Significant Improvement -
CHICAGO, April 28 /PRNewswire-FirstCall/ -- Data to be presented at the American Urological Association's (AUA) Annual Conference
|
| New Data Presented at AUA's Annual Conference Prove GELNIQUE(TM) (oxybutynin chloride) 10% gel is an Effective, Safe Option for Female Overactive Bladder (OAB) Patients |
27th April, 2009 |
Watson Pharmaceuticals, Inc. |
- First and Only Topical Gel for OAB to Launch in U.S. Next Month -
CHICAGO, April 27 /PRNewswire-FirstCall/ -- Data to be presented at the American Urological Association's (AUA) Annual
|
| Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting |
22nd April, 2009 |
Watson Pharmaceuticals, Inc. |
- Company to Highlight Data for its Two Newest Urological Products -
CORONA, Calif., April 22 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a global leader in the development
|
This page has been viewed 84 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Femring across BioPortfolio, or for Femring Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
